Fig. 1From: Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trialsStudy flow diagram based on Preferred Reporting Items for Systematic Reviews and Meta-analyses protocols (PRISMA-P) recommendationBack to article page